An investigation on behalf of investors in Travere Therapeutics, Inc. (NASDAQ:TVTX) shares over potential wrongdoing at Travere Therapeutics, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 09/29/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain directors at Travere Therapeutics, Inc.
Investors who purchased shares of Travere Therapeutics, Inc. (NASDAQ: TVTX) have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Travere Therapeutics, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Diego, CA based Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Travere Therapeutics, Inc. reported that its annual Total Revenue declined from $227.49 million in 2021 to $212.01 million in 2022, and that its Net Loss increased from $180.09 million in 2021 to $278.48 million in 2022.
Shares of Travere Therapeutics, Inc. (NASDAQ: TVTX) declined from $29.14 per share on August 08, 2022, to as low as $7.00 per share on September 21, 2023.
Those who purchased shares of Travere Therapeutics, Inc. (NASDAQ: TVTX) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.